Advertisement

Topics

I-Therapeutix, Inc. Company Profile

14:30 EST 16th December 2018 | BioPortfolio


News Articles [29 Associated News Articles listed on BioPortfolio]

Ocular Therapeutix Announces NDA Resubmission of DEXTENZA

Ocular Therapeutix (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announc...

Ocular Therapeutix files third NDA for ocular pain drug

A new drug application was filed for the third time by Ocular Therapeutix for Dextenza, or dexamethasone insert, 0.4 mg to tr -More- 

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced th...

FDA issues warning letter to Ocular Therapeutix over ReSure sealant

The letter relates to Ocular’s compliance with data collection and information reporting obligations in a post-approval Device Exposure Registry study required as a condition for approval of the Th...

Ocular Therapeutix™ to Present at the 2018 JMP Securities Life Sciences Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development and commercialization of innovative therapies for diseases and condition...

Ocular Therapeutix™ to Present at the 30th Annual Piper Jaffray Healthcare Conference

Ocular Therapeutix, Inc. (NASDAQ:OCUL) a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditio...

Ocular Therapeutix: Critical FDA Date Up Ahead

Ocular Therapeutix: Elucidating The Upcoming Regulatory Binary

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [5 Associated Companies listed on BioPortfolio]

Ocular Therapeutix, Inc. 

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of t...

Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. is a privately held company based in Bedford, MA, focused on the development and commercialization of ophthalmic therapeutic products using its proprietar...

Ora, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye using its p...

Ocular Therapeutix™, Inc.

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative therapies for diseases and conditions of the ...

I-Therapeutix, Inc.

More Information about "I-Therapeutix, Inc." on BioPortfolio

We have published hundreds of I-Therapeutix, Inc. news stories on BioPortfolio along with dozens of I-Therapeutix, Inc. Clinical Trials and PubMed Articles about I-Therapeutix, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of I-Therapeutix, Inc. Companies in our database. You can also find out about relevant I-Therapeutix, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record